The present application is directed to methods of treating epilepsy disorders such as Dravet Syndrome or Lennox-Gastaut syndrome comprising administering to a subject in need a therapeutically effective amount of a 5HT receptor agonist such as trazodone or lorcaserin. Additionally, these methods may also include administration of other anti-epileptic drugs. WO 2016/138138 PCT/US2016/019368 >4$O~~~ ..'.c*.*.e*.c .4.*'.4&.*.*c. ...$.. c.
5HT AGONISTS FOR TREATING DISORDERS